Skip to main content
Theo Heller, MD, Gastroenterology, Bethesda, MD, NIH Clinical Center

TheoHellerMD

Gastroenterology Bethesda, MD

Hepatology & Liver Transplantation

Chief, Translational Hepatology Section, NIDDK, NIH.

Dr. Heller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Heller's full profile

Already have an account?

  • Office

    National Institutes of Health, Translational Hepatology Section
    10 Center Drive, MSC 1800
    Bethesda, MD 20892
    Phone+1 301-496-1721
    Fax+1 301-402-0491
  • Is this information wrong?

Education & Training

  • University of Maryland
    University of MarylandFellowship, Gastroenterology, 1997 - 2000
  • MedStar Health/Georgetown University Hospital
    MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1990 - 1993
  • University of the Witwatersrand
    University of the WitwatersrandClass of 1989

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1992 - 2024

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Characterization of the Hepatosplenic and Portal Venous Findings in Patients with Proteus Syndrome  
    Theo Heller, MD, American Journal of Medical Genetics Part A
  • Rheological Determinants for Simultaneous Staging of Hepatic Fibrosis and Inflammation in Patients with Chronic Liver Disease  
    Ahmed M Gharib, Theo Heller, NMR in Biomedicine

Press Mentions

  • FDA Summit on Gene Therapy Risks Proves Timely
    FDA Summit on Gene Therapy Risks Proves TimelySeptember 7th, 2021
  • At FDA Meeting, Gene Therapy Experts Wrestle with Field's Blindspots
    At FDA Meeting, Gene Therapy Experts Wrestle with Field's BlindspotsSeptember 3rd, 2021
  • Liver Toxicity in Gene Therapy Trials Could Merit Stricter Entry Criteria
    Liver Toxicity in Gene Therapy Trials Could Merit Stricter Entry CriteriaSeptember 3rd, 2021

Hospital Affiliations